Heartburn Treatment Clinical Study

Heartburn is a common condition that develops when the contents of your stomach flow back into the esophagus and cause troublesome pain and discomfort. Unfortunately, about 40% of heartburn sufferers report continued symptoms after treatment with currently available prescription and over-the-counter medications. If you're ready to move on from heartburn, this study could be for you.

Sign up below or read further to learn more.

Clinical Study for Heartburn Treatments

MM slash DD slash YYYY
Do you have erosive or non-erosive esophagitis?
How would you describe yourself?*
*Please check all that apply.
Are you willing to share information about this study with interested friends and family members?
Word of mouth helps improve enrollment, thus reducing the time and cost to research the vaccine.
This field is for validation purposes and should be left unchanged.

About the Study

The purpose of this study is to determine the safety and efficacy of a research medication in the treatment of heartburn.  This medication is approved in several countries but not FDA approved for use in the United States.  Each participant will undergo an endoscopic exam (EDG) and  will participate in two phases of the study. All participants will receive 4 weeks of active treatment or placebo followed by 20 weeks of active treatment during the long term phase of the study.

Who qualifies?

*Must have heartburn at least 4 times per month

*18 years of age or older

* Must be willing to undergo an Endoscopic exam

* Basically healthy with no active ulcers or GI bleeding in the prior 30 days

* Not planning a hospitalization/surgical procedure

For more information and to see if you may be eligible to participate, call 615-329-2222 or complete the form on this web page.